Care Twentyone Corporation (2373) AI Stock Analysis

• Market Cap: ¥5.38B
• Dividend Yield: 3.5%
• Average Volume (3M): 7.71K
• Price to Earnings (P/E): 7.5
• Beta (1Y): 0.14
• Revenue Growth: 8.95%
• EPS Growth: N/A
• Country: JP
• Employees: 6,153
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Care Facilities
• EPS (TTM): 3.62
• Shares Outstanding: 14,844,000
• 10 Day Avg. Volume: 3,740
• 30 Day Avg. Volume: 7,706
• PEG Ratio: -0.49
• Price to Book (P/B): 1.57
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 54.99
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: ¥406.00 ▲(1.50%Upside)

Care Twentyone Corporation's overall stock score is primarily impacted by moderate financial performance, with challenges in profitability and cash flow management. Despite these issues, the stock's valuation is favorable, indicating potential undervaluation and an attractive dividend yield. Technical analysis shows neutral momentum, suggesting a period of consolidation. High leverage remains a key risk factor, highlighting the need for improved operational efficiency.

Care Twentyone Corporation Business Overview & Revenue Model

Company Description

Care Twentyone Corporation (2373) is a company operating within the healthcare sector, primarily focusing on providing comprehensive care services. The company specializes in senior care, rehabilitation, and other health-related services. It aims to deliver quality and compassionate healthcare solutions through its network of facilities and experienced professionals.

How the Company Makes Money

Care Twentyone Corporation generates revenue through various streams including service fees from its care facilities, rehabilitation centers, and healthcare programs. The company charges clients for the care services provided, which may include long-term care, short-term rehabilitation, and specialized medical treatments. Additionally, partnerships with healthcare providers and insurers play a crucial role in driving revenue by expanding service offerings and client base. Government funding and subsidies may also contribute to its earnings, particularly in regions where such support for healthcare services is available.

Care Twentyone Corporation Financial Statement Overview

Summary

Care Twentyone Corporation exhibits moderate financial health with steady revenue growth but faces challenges in profitability and cash flow management. High leverage remains a concern, potentially impacting future financial flexibility. The company needs to focus on improving operational efficiency and cash generation to enhance financial stability and shareholder value.

Income Statement

The income statement shows a modest revenue growth of 10.45% in the latest year, indicating a steady growth trajectory. However, the company is struggling with profitability, as evidenced by a negative EBIT and declining net income. Gross profit margin remains stable, but net profit margin is low due to high operational costs, impacting overall profitability. The negative EBIT margin suggests operational inefficiencies.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio, indicating significant leverage which poses financial risk. Although the equity ratio is relatively low, the company maintains a reasonable return on equity (ROE), suggesting that it uses its equity efficiently despite the high debt level. The company's high liabilities relative to its equity may constrain its financial flexibility.

Cash Flow

Cash flow analysis shows volatility with a significant decline in free cash flow in the latest year. The free cash flow to net income ratio is concerning, highlighting potential liquidity issues. Operating cash flow is positive but has decreased significantly, indicating challenges in converting revenue into cash. This trend may affect the company's ability to fund operations and growth without relying on external financing.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
44.34B	45.40B	41.10B	38.40B	36.36B	33.98B
	Gross Profit
9.44B	9.66B	9.01B	9.27B	8.73B	7.67B
	EBIT
-490.10M	-460.65M	-401.04M	1.11B	1.51B	1.34B
	EBITDA
1.02B	2.20B	2.33B	3.12B	3.53B	3.11B
	Net Income Common Stockholders
-118.07M	278.42M	6.16M	630.49M	937.08M	704.64M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.23B	3.08B	2.61B	1.88B	2.83B	2.94B
	Total Assets
33.31B	31.67B	31.82B	36.38B	37.60B	36.20B
	Total Debt
20.43B	19.49B	18.34B	22.51B	22.96B	24.07B
	Net Debt
17.20B	16.42B	15.73B	20.63B	20.13B	21.14B
	Total Liabilities
28.50B	26.94B	26.30B	29.90B	30.83B	31.12B
	Stockholders Equity
4.80B	4.71B	5.50B	6.46B	6.77B	5.07B
Cash Flow		Free Cash Flow
0.00	-502.44M	479.68M	184.12M	1.42B	2.14B
	Operating Cash Flow
0.00	709.85M	2.14B	1.11B	2.61B	2.88B
	Investing Cash Flow
0.00	-1.02B	-2.60B	-1.39B	-1.38B	-1.11B
	Financing Cash Flow
0.00	782.01M	1.20B	-679.93M	-1.33B	-77.19M

Care Twentyone Corporation Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 400.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Positive. The current price of 400 is above the 20-day moving average (MA) of 395.50, above the 50-day MA of 390.89, and above the 200-day MA of 388.59, indicating a bullish trend. The MACD of 2.20 indicates Negative momentum. The RSI at 59.30 is Neutral, neither overbought nor oversold. The STOCH value of 87.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2373.

Care Twentyone Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7129	75 Outperform	¥3.04B	9.54		3.13%	4.85%	4759.88%
2435	69 Neutral	¥2.38B	6.86		2.83%	3.03%	70.93%
2425	69 Neutral	¥2.99B	7.99		2.54%	2.33%	-0.96%
7091	64 Neutral	¥3.96B	10.76		―	15.25%	93.03%
2373	58 Neutral	¥5.38B	7.55		3.50%	8.95%	―
Sector *	54 Neutral	$5.37B	3.26	-45.10%	3.30%	16.81%	0.02%
9229	53 Neutral	¥21.59B	159.73		2.94%	29.51%	-176.55%